Example: Heart Attack

Clinical Trials on Homologous Wasting Disease

Total 828 results

NCT04144036

Recruiting

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

Conditions: Graft-versus-host Disease
NCT03093805

Completed

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin

Conditions: Graft Vs Host Disease
NCT01713400

Completed

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease

Conditions: Graft vs. Host Disease
NCT02144025

Completed

Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT

Conditions: Graft-Versus-Host Disease
NCT03764228

Recruiting

Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation

Conditions: Acute-graft-versus-host Disease
NCT01972438

Terminated

A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients

Conditions: Graft vs Host Disease
NCT03605940

Not yet recruiting

A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host Disease

Conditions: Acute-graft-versus-host Disease
NCT02385019

Unknown status

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Conditions: Graft vs Host Disease
NCT04291261

Active, not recruiting

Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease

Conditions: Acute-graft-versus-host Disease
NCT02055625

Withdrawn

Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease

Conditions: Graft -Versus-host-disease
NCT02291770

Unknown status

Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells

Conditions: Chronic Graft-Versus-Host Disease
NCT01954979

Active, not recruiting

A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft Versus Host Disease
NCT01066598

Terminated

A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)

Conditions: Graft Versus Host Disease
NCT04200365

Recruiting

A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft-versus-host-disease
NCT02123966

Terminated

An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease

Conditions: Chronic Graft-versus-Host-Disease; Oral Mucosal Disease Due to Graft-versus-host Disease
NCT04204122

Recruiting

Vigamox Treatment for Ocular Graft-Versus-Host Disease

Conditions: Ocular Graft-versus-host Disease
NCT00053976

Completed

Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease

Conditions: Graft Versus Host Disease
NCT04710576

Recruiting

A Study of Axatilimab at 3 Different Doses in Patients With Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft-versus-host-disease
NCT00031824

Completed

Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

Conditions: Graft Versus Host Disease
NCT02379442

Terminated

Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids

Conditions: Graft-Versus-Host Disease
NCT00055666

Completed

Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract

Conditions: Graft Versus Host Disease
NCT01369914

Completed

The Natural History of Graft-Versus-Host Disease in the Eyes

Conditions: Graft-Versus-Host Disease
NCT03774082

Recruiting

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Conditions: Graft vs Host Disease
NCT01589549

Unknown status

Mesenchymal Stromal Cells for Acute Graft Versus Host Disease

Conditions: Acute GVH Disease
NCT01161628

Completed

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Conditions: Chronic Graft-versus-host Disease